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Several  studies  have  sought  to  clarify  the  association  between  adolescent  obesity  and psychological  dis-
tress. Recently,  a biological  link  between  leptin  resistance  and depression  has been proposed.  The  aim  of
the  present  study  was  to examine  changes  in leptin  concentrations  as  a potential  predictor  of  reduced
depression  symptoms  in  obese  adolescents  during  long-term  interdisciplinary  weight  loss  therapy.
Seventy-ﬁve  obese  adolescents  (age:  16.28  ± 2.37 years;  BMI:  35.65 ± 4.64 kg/m2)  engaged  in  a long-term
interdisciplinary  therapy  for weight  loss.  They  were  evaluated  at baseline  and  after  1 year  of  treat-
ment  for body  composition,  serum  analyses  and  depression  symptomatology.  After  therapy,  body mass
BMI, fat  mass  (%  and  kg),  waist  circumference,  visceral,  subcutaneous  and  visceral/subcutaneous  fat  and
depression symptoms  decreased  and  lean  mass  (%) increased  signiﬁcantly.  There  was  an  improvement  ineptin resistance
besity
dolescents
nﬂammation
inﬂammatory  proﬁles  with  a signiﬁcant  reduction  in  leptin  and  increase  in  adiponectin.  Regression  anal-
yses showed  that  decreased  leptin  predicted  amelioration  in depression  symptoms  independent  of  age,
gender and changes  in visceral  fat,  body  mass,  fat mass  (%)  and  leptin/adiponectin  ratio.  These  associa-
tions  appear  stronger  in girls  than  boys.  The  attenuation  of hyperleptinemia  appears  to play  an  important
role  in the  association  between  weight  loss  and  depression,  particularly  in obese  girls.
©  2015  Elsevier  Inc.  All  rights  reserved.ntroduction
Obesity is an inﬂammatory multifactorial disease that has
ecome a global epidemic reaching high prevalence in both devel-
ped and developing countries. The World Health Organization [54]
eports that over 1.5 billion people were overweight and more than
alf a billion were obese worldwide. In Brazil, 50% of the adult
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196-9781/© 2015 Elsevier Inc. All rights reserved.population and 30% of adolescents are overweight or obese, which
represents a major public health problem [25].
There are many studies demonstrating strong associations
between obesity and depression. It has been demonstrated that
obesity increases the risk of poor mental health, including greater
levels of unhappiness, pessimism, low positive affect, dissatisfac-
tion with life and suicidal behaviors [3,5,16,26,37,46,48,49].
Leptin is an adipokine that is expressed by adipose tissue and
thought to play a key role in the neuroendocrine control of energy
balance. Recent studies have established that obese individuals
frequently present with elevated plasma leptin concentrations,
causing a state of hyperleptinemia, in which leptin insensitivity or
leptin resistance is likely. There are some important implications of
leptin resistance in obesity. It is known that this condition hinders
the weight loss process and it is not easily reversed. Previous stud-
ies have shown that the leptin resistance seems to be controlled
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nly after massive losses of weight and even so, some individuals
emains in a hyperleptinemic state [10,34].
Importantly, in addition to impair the control of energy bal-
nce, the state of hyperleptinemia is related to inﬂammatory
esponse in obesity [4,30,51] and a positive association between
ro-inﬂammatory cytokines and leptin concentrations in obesity
nd its related comorbidities has been well established in the liter-
ture and in previous studies from our group. Leptin has emerged
s a key player in the pro-inﬂammatory process in obesity and
etabolic syndrome and is, therefore, considered a pivotal link
n obesity-related diseases, enhancing, for example, cardiovascu-
ar risks associated with obesity [14,51]. Moreover, recent ﬁndings
ave shown that in addition to promoting the inﬂammatory process
f obesity, hyperleptinemia impairs the anti-inﬂammatory effects
f adiponectin [10].
A relationship between inﬂammatory status in obesity and
epression has been proposed [52]. Studies have uncovered a
otential biological link between leptin concentrations and depres-
ion in older male individuals in the presence of abdominal obesity,
aising the possibility that leptin resistance could be important.
he authors suggests that, despite increased leptin circulating lev-
ls in obesity, leptin resistance due to impaired transport across
he blood-brain barrier, reduced function of the leptin receptor and
efects in leptin signal transduction, may  explain these results [38].
oreover, in a large epidemiological and longitudinal study, Pasco
t al. [45] demonstrated that serum leptin predicted the later devel-
pment of major depression. However, the relationship between
epression and leptin remains inconclusive with studies indicating
ower or higher levels of leptin in patients with depression, while
thers report no association [2,11,17,27,29].
In obese adolescents, there have been no studies examining
he association between depression and leptinemia. Therefore,
esearch is needed to explore effective treatment methods for
mproving physical and mental health in the adolescent population
nd to clarify the mediating processes behind such improvements.
he aims of the present study were ﬁrstly to examine the effect of an
nterdisciplinary long-term weight loss therapy on leptinemia and
epression; and secondly to examine post-therapy changes in lep-
in concentrations as a predictor of reduced depression symptoms
n obese adolescents.
ethods
articipants
Individuals were initially recruited by advertisement in local
edia before being medically screened for inclusion in the Federal
niversity of São Paulo Interdisciplinary Obesity Group Pro-
ram [10]. Seventy-ﬁve treatment-seeking obese adolescents (30
oys and 45 girls) with a mean age of 16.28 ± 2.37 years were
ncluded (age ranged from 13 to 19). Mean body mass index was
5.65 ± 4.64 kg/m2 (BMI ≥ 95th [7]) and postpubertal stage V based
n the Tanner and Whitehouse stages [53]. Exclusion criteria were:
lteration in exercise electrocardiography; known history of dis-
ases related to the immune system; use of medication and/or
ietary supplements that alter metabolism in the 6 months pre-
eding the start of the study; genetic, osteo-muscular, mental or
ndocrine diseases; current treatment – pharmacological and/or
sychotherapeutic – for psychological diseases, such as depression;
nd prior chronic consumption of alcohol or recreational drugs.
This study was formally approved by the ethical committee of
he Federal University of São Paulo (#103310/12) and is a regis-
ered Clinical Trial (NCT 0135/7883). All participants and/or their
arents gave informed consent and agreed to participate on a vol-
ntary basis. This study was carried out in accordance with theeptides 65 (2015) 20–28 21
principles of the Declaration of Helsinki. Participants were sub-
mitted to anthropometric, body composition, serum analysis and
psychological symptom evaluations at baseline and after long-term
interdisciplinary therapy (1 year).
Measurements
Anthropometric evaluation and body composition
Anthropometric measurements were assessed with individuals
standing, wearing light clothing and no shoes. They were weighed
on a Filizola scale (São Paulo, SP, Brazil) to the nearest 0.1 kg
and height was measured using a wall-mounted Sanny stadiome-
ter (model ES 2030, São Paulo, SP, Brazil) to the nearest 0.5 cm.
Body mass index was  calculated as body weight divided by height
squared. Body composition was estimated by air displacement
plethysmography using the BODPOD body composition analyzer
(version 1.69; Life Measurement Instruments, Concord, CA) [13].
Serum analysis
Blood collection was performed after a 12-h overnight fast by
venipuncture in the forearm. The plasma was  separated and ana-
lyzed after collection. Serum concentrations of adiponectin and
leptin were measured using a commercially available enzyme-
linked immunosorbent assay (ELISA) kit from R&D Systems
(Minneapolis, MN,  USA) according to the manufacturer’s instruc-
tions. Leptin data were analyzed according to reference values
described by Gutin et al. [18].
Visceral and subcutaneous adiposity measurements
The same physician specialist in imaging diagnostics performed
abdominal ultrasonographic measurements of visceral and sub-
cutaneous fat tissues at baseline and after therapy. A 3.5-MHz
multifrequency transducer (broad band) was  used to reduce the
risk of misclassiﬁcation and the intra-examination coefﬁcient of
variation for ultrasound (US) was  0.8%. Subcutaneous fat was
deﬁned as the distance between the skin and superﬁcial plane of
the rectus abdominal muscle and visceral fat was  deﬁned as the dis-
tance between the deep plane of the same muscle and the anterior
wall of the aorta [47].
Depression symptoms
Depression symptoms were evaluated using the Beck Depres-
sion Inventory (BDI), a 21-item self-report questionnaire which
identiﬁes symptoms of depression in the general population.
The BDI has been translated into Portuguese and validated in
the Brazilian population [9]. Each item presents four statements
representing escalating severity of depression symptoms. The
instrument assesses the severity of depression with the following
standard: no concern (0–11), mild (12–19), moderate (20–35) and
severe (36–63).
Therapy protocol
The therapy protocol consisted of interdisciplinary group ther-
apy three times per week. The adolescents took part in clinical,
nutritional and psychological-based therapy sessions, as well as aThe clinical therapy consisted of individual clinical consulta-
tions once a month with an endocrinologist physician. Volunteers
attended this meeting accompanied by their parents or guardians.
Weight loss and medical test results were discussed.
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utritional therapy
The nutritional group therapy took place once a week with the
oal of improving nutrition education. The main aims were to assist
nd orient healthy food choices, providing information about the
ood pyramid, loss diets versus fad diets, food labels, fat-free and
ow-calorie foods, fats, fast foods, healthy snacks, functional foods,
tc. Monthly, participants were given an individual nutrition con-
ultation. Energy intake was set at the levels recommended by the
ietary reference intake for subjects with low levels of physical
ctivity and of the same age and gender following a balanced diet
43]. No pharmacotherapies or antioxidants were recommended.
sychological therapy
The psychological group therapy took place once a week with
he aim to discuss and equip the skills to manage emotional issues
ssociated with obesity: binge eating, bulimia nervosa, depression,
nxiety, body image, the relationship between food and feelings,
tress, family problems, etc. In each psychological session, the
onsequences for health and the relationship with the cause and
aintenance of obesity were debated with the adolescents. Fur-
hermore, the therapy guided the volunteers’ ways of dealing
ith these issues, favoring treatment success. All study volunteers
eceived individual psychological consultations and those who  pre-
ented greater difﬁculty dealing with behavioral and/or emotional
roblems were systematically consulted.
xercise program
The physical exercise program consisted of supervised aerobic
nd resistance exercise training three times per week. Participants
erformed 30 min  of aerobic exercise per session (bicycle or tread-
ill) and about 30 min  of resistance exercises based on guidelines
rom the American College of Sports Medicine [1]. During 2 weeks,
ll subjects familiarized themselves with the training protocol,
efore starting the program. The aerobic exercises were conducted
t the intensity of effort for the ﬁrst ventilatory threshold deter-
ined by direct gas analysis (50–70% of maximum oxygen uptake)
nd controlled by a frequency rate, as determined by the results of
n initial oxygen uptake test for aerobic exercise. The cardiac fre-
uency was controlled by the physiologists and it was measured
ith a cardiometer at intervals of 5 min  during all training sessions
Polar Model FS1 dark blue).
tatistical analyses
Data were analyzed using STATISTICA 7.0 (StatSoft, Tulsa, OK,
SA) and the ˛-level was set at <0.05. Kolmogorov–Smirnov test
as used to verify distributional assumptions. Variables with
ormal distributions are expressed as means ± standard devia-
ion and variables without normal distribution are expressed as
edians (minimum − maximum). Comparisons between values
t baseline and after therapy and between groups were made
sing ANOVA two-way for parametric variables and Wilcoxon and
ann–Whitney t-test for non-parametric variables. Correlations
etween changes () in depression and leptin with the analyzed
ariables were performed using Pearson’s and Spearman’s correla-
ions. Simple and multiple linear regression analyses were used to
erify the inﬂuence of changes in leptinemia on depression symp-
oms. BMI  Z-scores were obtained using EPI INFO Software, version
.5.3 (CDC, Atlanta, GA, USA).
esultsA total of 75 obese adolescents (30 boys and 45 girls) completed
 year of therapy with completion of more than 75% of treatment
essions. As can be seen in Table 1, it was observed in the total
ample a signiﬁcant decrease in body mass, BMI, zBMI and bodyeptides 65 (2015) 20–28
fat (kg and %) with a corresponding increase in lean mass (%).
There were also decreases in waist circumference, visceral fat and
visceral/subcutaneous fat ratio. Adiponectin and leptin concentra-
tions, as well as adiponectin/leptin and leptin/adiponectin ratio,
were all signiﬁcantly different from baseline to post therapy. Fur-
thermore, there was a signiﬁcant decrease in depression symptoms
in the total sample.
There were some differences between gender groups. At base-
line, boys were higher than girls and had signiﬁcantly greater values
on lean mass (kg and %), visceral fat and visceral/subcutaneous
ratio. On the other hand, girls had signiﬁcantly higher fat mass (%),
subcutaneous fat and leptin concentration. After therapy, girls had
the same result as the total sample and boys did not have signif-
icantly lower visceral/subcutaneous fat ratio. The absolute value
of change () was  similar between boys and girls on the parame-
ters evaluated, with exception of adiponectin/leptin ratio, for which
boys had a signiﬁcantly greater increase and zBMI on which boys
had a greater decrease (Table 1).
Correlations between leptin and depression with changes in body
composition
It was demonstrated that changes in leptin concentrations were
positively correlated with changes in body mass, BMI, fat mass
(% and kg), visceral fat, subcutaneous fat, leptin/adiponectin ratio
and depression symptoms. Moreover, changes in leptin were nega-
tively correlated with changes in adiponectin/leptin ratio and lean
mass (%). Considering groups by gender, changes in leptin remained
positively correlated in boys with changes in body mass, BMI,
subcutaneous fat and leptin/adiponectin ratio and negatively cor-
related with changes in adiponectin/leptin ratio. In girls, changes in
leptin remained positively correlated with changes in body mass,
BMI, fat mass (% and kg), subcutaneous fat, leptin/adiponectin ratio
and depression symptoms and negatively correlated with changes
in lean mass (%) and adiponectin/leptin ratio (Table 2).
On examination of psychological symptoms, change in depres-
sion scores was correlated with a number of changes in
anthropometric and body composition proﬁles after long-term
weight loss therapy. Speciﬁcally, positive correlations were
observed between depression symptoms and changes in body
mass, BMI, fat mass (kg) and subcutaneous fat. Furthermore,
changes in depression symptoms were correlated with inﬂamma-
tory status as indicated by positive correlations with changes in
leptin concentrations and leptin/adiponectin ratio. In boys, changes
in depression symptoms remained positively correlated only with
changes in subcutaneous fat. On the other hand, in girls, the positive
correlations remained between changes in depression and changes
in body mass, BMI, subcutaneous fat, leptin, leptin/adiponectin
ratio. In addition, the negative correlation between changes in
depression symptoms and changes in adiponectin/leptin ratio also
remained in girls (Table 2).
Regressions analysis
The simple linear regression analysis demonstrated that
changes in leptin were signiﬁcantly associated with changes in
depression symptoms following long-term interdisciplinary ther-
apy (  ˇ = 0.37; p = 0.001). When analyzed separately, changes in
leptin remained correlated to changes in depression symptoms in
girls (  ˇ = 0.49; p < 0.001), but not in boys (  ˇ = 0.22; p = 0.25) (Fig. 1).
To strengthen the interpretation of these ﬁndings, a multiple
regression analysis was  performed to assess whether change in
leptin concentrations was  an independent predictor of change in
depression symptoms after controlling for confounding factors. In
the subsequent models examined, change in leptin was  upheld
as a signiﬁcant predictor of change in depression in the total
J.P.d.
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Table 1
Effect of therapy on anthropometric, inﬂammatory and psychological proﬁle on the total sample, boys and girls.
Total sample (N = 75) Boys (N = 30) Girls (N = 45)
Baseline After therapy  Baseline After therapy  Baseline After therapy 
Age (years) 16.28 ± 2.37 16.44 ± 1.39 16.17 ± 2.86
Body  mass (kg) 100.99 ± 15.44 90.46 ± 13.66* −10.54 ± 7.58 105.14 ± 15.60 93.64 ± 15.38* −11.49 ± 6.98 98.23 ± 14.87 88.33 ± 12.09* −9.90 ± 7.97
Stature  (m) 1.68 ± 0.09 1.69 ± 0.09* −0.01 ± 0.01 1.75 ± 0.07 1.76 ± 0.07* 0.01 ± 0.01 1.63 ± 0.06ˇ 1.64 ± 0.06*, 0.01 ± 0.01
BMI  (kg/m2) 35.75 ± 4.64 31.71 ± 4.15* −4.04 ± 2.79 34.22 ± 3.65 30.09 ± 3.83* −4.13 ± 2.39 36.76 ± 4.97 32.78 ± 4.04* −3.98 ± 3.05
zBMI  2.21 ± 0.27 1.83 ± 0.41* −0.38 ± 0.30 2.29 ± 0.29 1.79 ± 0.50 * −0.49 ± 0.36 2.15 ± 0.25 1.85 ± 0.33 * −0.29 ± 0.22¥
Fat mass (kg) 44.99 ± 10.69 34.20 ± 9.98* −10.19 ± 9.70 42.45 ± 10.43 30.38 ± 10.70* −12.07 ± 7.44 46.71 ± 10.64 36.75 ± 8.68* −8.93 ± 10.85
Fat  mass (%) 44.59 ± 6.65 37.44 ± 7.93* −7.15 ± 5.35 40.01 ± 5.77 31.79 ± 7.42* −8.21 ± 5.83 47.65 ± 5.34ˇ 41.21 ± 5.76*, −6.45 ± 4.94
Lean  mass (kg) 55.73 ± 9.18 56.52 ± 9.27 0.78 ± 9.36 62.75 ± 8.35 63.61 ± 8.38 0.86 ± 3.92 50.94 ± 6.18ˇ 51.68 ± 6.28 0.73 ± 11.71
Lean  mass (%) 55.59 ± 6.49 62.56 ± 7.93* 7.71 ± 7.90 59.99 ± 5.77 68.21 ± 7.42* 8.21 ± 5.83 52.59 ± 5.14ˇ 58.80 ± 5.76*, 7.38 ± 9.08
Waist  circumference
(cm)
101.54 ± 10.60 91.79 ± 10.83* −10.14 ± 10.69 103.87 ± 8.80 91.42 ± 8.32* −12.42 ± 10.37 99.98 ± 11.48 91.99 ± 12.12* −8.89 ± 10.83
Visceral  fat (cm) 4.24 ± 1.21 2.91 ± 1.13* −1.42 ± 1.19 4.75 ± 1.31 3.48 ± 1.25* −1.55 ± 1.52 3.90 ± 1.02ˇ 2.56 ± 0.90*, −1.34 ± 0.93
Subcutaneous  fat (cm) 3.86 ± 0.82 3.05 ± 0.74* −0.94 ± 0.94 3.54 ± 0.67 2.62 ± 0.67* −1.13 ± 0.01 4.07 ± 0.84ˇ 3.33 ± 0.66*, −0.81 ± 0.88
Visceral/subcutaneous
(cm)
1.15  ± 0.40 1.00 ± 0.44* −0.15 ± 0.39 1.38 ± 0.40 1.36 ± 0.44 −0.03 ± 0.47 1.00 ± 0.33ˇ 0.78 ± 0.27*, −0.22 ± 0.33
Adiponectin  (ug/l) 3.57 (0.75–13.86) 4.29 (0.98–16.14)* 0.99 (−11.63–12.64) 3.74 (0.75–13.86) 4.17 (0.98–16.14)* 0.96 (−4.47–6.67) 3.51 (0.88–12.93) 5.01 (1.80–15.72)* 1.00 (−11.63–12.64)
Leptin  (ng/ml) 36.88 ± 19.36 25.12 ± 14.46* −11.77 ± 17.20 28.68 ± 22.49 12.92 ± 8.86* −15.75 ± 20.01 42.36 ± 14.85ˇ 33.25 ± 11.44*, −9.11 ± 14.69
Adipo/lep  0.10 (0.02–6.53) 0.21 (0.00–6.00)* 0.09 (−2.92–5.47) 0.11 (0.02–6.53) 0.38 (0.04–6.00)* 0.18 (−2.92–5.47) 0.09 (0.03–0.53) 0.14 (0.00–1.18)*, 0.06 (−0.29–1.08)¥
Lep/adipo 11.69 ± 9.05 6.08 ± 5.55* −5.73 ± 7.07 11.05 ± 10.19 4.30 ± 5.14* −6.76 ± 8.10 12.14 ± 8.25 7.38 ± 5.54*, −4.97 ± 6.22
Depression  symptoms
(BDI)
14.93 ± 8.15 8.09 ± 6.33* −6.84 ± 7.60 14.67 ± 9.11 5.90 ± 5.09* −8.77 ± 8.55 15.11 ± 7.54 9.56 ± 6.69* −5.56 ± 6.69
, absolute value of changes.
Values are: mean ± standard deviation or medians (minimum − maximum).
* Difference between baseline and after therapy p ≤ 0.05.
 Difference between boys and girls at baseline p ≤ 0.05.
 Difference between boys and girls after therapy p ≤ 0.05.
¥ Difference of  between boys and girls p ≤ 0.05.
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Table 2
Correlations between leptin and depression with the analyzed variables in total sample, boys and girls.
 leptin concentration  depression symptoms
Total sample Boys Girls Total sample Boys Girls
 body mass (kg) 0.69** 0.38* 0.81** 0.29* 0.19 0.35*
 BMI  (kg/m2) 0.71** 0.44* 0.82** 0.30* 0.23 0.37*
 fat mass (kg) 0.37* 0.36 0.35* 0.25* 0.17 0.28
  fat mass (%) 0.44** 0.3 0.51** 0.17 0.22 0.09
  lean mass (kg) −0.01 0.09 −0.03 0.18 0.02 0.27
  lean mass (%) −0.37* −0.3 −0.39* −0.05 −0.22 0.02
  waist circumference (cm) 0.17 0.23 0.12 0.19 0.3 0.11
  visceral fat (cm) 0.27* 0.28 0.29 0.03 −0.1 0.18
  subcutaneous fat (cm) 0.70** 0.60* 0.74** 0.41** 0.42* 0.42*
 visceral/subcutaneous (cm) −0.13 −0.01 −0.19 −0.23 −0.33 −0.05
  adiponectin (ug/l) 0.13 0.27 0.03 0.06 0.14 −0.03
  leptin (ng/ml) 1 1 1 0.37* 0.21 0.49*
 adipo/lep −0.56* −0.45* −0.64* −0.2 0.05 −0.33*
 lep/adipo 0.60* 0.52* 0.63* 0.31* 0.16 0.43*
 depression symptoms (BDI) 0.37* 0.21 0.49* 1 1 1
* p < 0.05.
** p < 0.01.
F anges
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cig. 1. Simple linear regression between changes in leptin concentration and ch
nterdisciplinary weight loss therapy.
ample independently of change in visceral fat, body mass, fat
ass (%), and leptin/adiponectin ratio. The changes in zBMI scores
howed to share with changes in leptin the role as predictor of
ecreased depressive symptoms in the total sample (Table 3). How-
ver, when the sample was analyzed according to gender groups,
eptin remained as an independent predictor of changes in depres-
ion symptoms in girls, but not in boys, including the model that
onsidered the zBMI, as can be seen in Table 3. in depression symptoms on the total sample (a), boys (b) and girls (c) during
Discussion
Individuals with obesity frequently present with a state of
hyperleptinemia, indicative of leptin insensitivity or resistance,
and recent studies have suggested that leptin may  have a role
in the relationship between obesity and depression [10,24]. The
present study investigated the role of reduced leptin concen-
trations during long term interdisciplinary weight loss therapy
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Table  3
Multiple regression analysis to determine predictors of changes in depressive symptoms in obese adolescents after long-term interdisciplinary therapy.
 depression symptoms
Total sample Boys Girls
 ˇ p  ˇ p  ˇ p
 visceral fat −0.13 0.283 −0.247 0.253 0.044 0.76
  leptin 0.418 0.001 0.3 0.168 0.483 0.001
Gender −0.157 0.168 – – – –
Age  0.157 0.889 −0.403 0.037 0.254 0.075
  visceral fat −0.128 0.292 −0.377 0.079 0.079 0.575
  leptin 0.386 0.002 0.376 0.072 0.545 <0.001
Gender −0.145 0.193 – – – –
Age  0.068 0.551 −0.283 0.133 0.235 0.105
  body mass 0.156 0.257 0.128 0.502 −0.02 0.934
  leptin 0.226 0.051 0.195 0.309 0.574 0.014
Gender −0.065 0.560 – – – –
Age  0.073 0.499 −0.244 0.179 0.244 0.080
  zBMI 0.292 0.014 0.286 0.117 0.101 0.566
  leptin 0.277 0.016 0.221 0.214 0.493 0.008
Gender −0.126 0.256 – – – –
Age  0.073 0.518 −0.287 0.125 0.287 0.04
  fat mass (kg) 0.168 0.156 0.128 0.495 0.198 0.169
  leptin 0.308 0.009 0.206 0.275 0.502 <0.001
Gender −0.147 0.2 – – – –
Age  0.367 0.747 −0.294 0.119 0.243 0.088
  leptin/adiponectin 0.099 0.424 0.039 0.84 0.133 0.404
  leptin 0.315 0.001 0.219 0.266 0.508 <0.001
Gender −0.16 0.152 – – – –
Age  0.072 0.524 −0.293 0.113 0.24 0.09
  BMI 0.19 0.161 0.204 0.277 0.00 0.98
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alues in bold are statistically signiﬁcant (p < 0.05).
s a predictor of improved depressive symptoms in obese
dolescents.
As stated before, controlling leptinemia is important for restor-
ng the protective effect of this adipokine. Hyperleptinemic state
as a strong pathological inﬂuence in body weight control and is
lso associated to the subclinical inﬂammatory state of obesity,
eing related to the development of obesity-related diseases, such
s cardiovascular diseases, insulin resistance and metabolic syn-
rome. This condition also impairs the effects of adiponectin, an
nti-atherogenic adipokine in obese individuals [4,34]. However,
ithin normal physiological range, leptin function contributes to
euroendocrine control of energy balance, controlling satiety sig-
als and, in this sense, may  be crucial to weight control [15].
The most important ﬁnding of this study was the conﬁrmation
f change in leptin as a potential mechanism associating obesity
nd depression independently of changes in adiposity. In this sam-
le, decreased leptin concentrations after therapy was correlated
o decreased depression symptoms and leptin was conﬁrmed as an
ndependent predictor of depression symptoms after controlling
or adiposity measures and other confounding factors including
ender, age, changes in body mass, fat mass (%), visceral fat and
eptin/adiponectin ratio. These results remained in girls, but not
n boys when the sample was analyzed separately according to
ender. Furthermore, improvement in depression symptoms was
orrelated with the decrease in the leptin/adiponectin ratio, which
s an important indicator of inﬂammatory status [57].
Indeed, according to Marazziti et al. [35], animal model
nvestigations have demonstrated that leptin could have an
ntidepressant-like efﬁcacy and, although there are high circulat-
ng levels of leptin in the obese, they are resistant to its effects. The
uthors pointed out that this hypothesis is supported by studies
sing diet-induced obese mice and suggest that, similarly in obese
ndividuals, leptin resistance could underlie depressive symptoms.0.18 0.337 0.55 0.018
Accordingly, Yamada et al. [55] suggested that obesity-associated
depression in mice might be partly caused to impaired leptin
activity in the hippocampus, an important brain region for reg-
ulation of the depressive state. The authors highlights that diet
induced obesity mice do not exhibit an increase in the number
of c-Fos-immunoreactive cells (a neuronal activation marker) in
the hippocampus in the response to leptin administration. Differ-
ently, control diet mice respond to leptin, increasing the number
of c-Fos immunoreactive cells in the hippocampus, which leads to
exhibition of antidepressive behaviors. Thus, it is suggested that in
diet induced obese mice, the leptin resistance results in a severe
depressive state despite hyperleptinemia. This sense, the present
investigation provides some support for this hypothesis in human
subjects, since demonstrated that the attenuation of leptinemia in
obese adolescents could be, at least in part, responsible for improv-
ing the mental health status of these individuals.
Furthermore, according to Lu [32], it can be suggested that lep-
tin modulates hypothalamic–pituitary–adrenal (HPA) axis function
at multiple levels and it is one consistent explanation about how
leptin can affect mood. Dysregulation of the HPA axis is reported in
patients with major depression disorder and seems to play a role
in the pathophysiology of the disease [42].
In agreement, Hryhorczuk et al. [24] concluded from a review of
the literature that leptin resistance is a plausible mechanism under-
lying depression in obesity because leptin resistance appears to
affect emotions and mood through HPA activity. Thus, the reduction
in leptin concentration observed in this study may  have improved
the regulation of HPA axis activity, promoting amelioration in
depressive symptoms. Nonetheless, this hypothesis cannot be con-
ﬁrmed in the present investigation because it was not planned to
assess HPA axis activity, although it should be addressed in future
studies. Additionally, Antonijevic et al. [2] pointed out that leptin
inhibits NPY release from the neurons in the hypothalamus, which
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ight contribute to the symptoms observed in depression, since
PY stimulates food intake and reduces anxiety.
It is important to note that in the present study the multiple
egression analysis showed that decreases in leptin concentra-
ions during weight loss (and an assumed attenuation of leptin
esistance) predicted improvement in depressive symptoms inde-
endently of body composition changes after long-term weight
oss treatment. When the zBMI score was included in the regres-
ion model, it was observed that this variable shared with changes
n leptin the role as predictor of decreased depressive symptoms
fter therapy. However, it is worth mentioning that zBMI it is not
uch an objective measure of adiposity as visceral fat or fat mass,
or example, and this sharing role of zBMI score as an predictor of
epressive symptoms could be related to psychosocial aspects on
he etiology of depression, such as increased satisfaction in body
mage and quality of life after weight loss [6,36].
Nevertheless, in contrast, some studies have reported different
esults suggesting the role of adiposity on the leptin-depression
elationship [38,39,41], raising the need for further investigations
o clarify these associations.
Further, although change in leptin concentration was  a predictor
f fewer depressive symptoms after therapy independent of gender
ˇ = 0.385; p = 0.002), when boys and girls were analyzed separately
his result remained only for girls (  ˇ = 0.545; p < 0.001), indicating
hat these associations may  be stronger in girls than boys.
It is worth noting that on average girls had greater values of
at mass and leptin at baseline than boys, indicating a worse body
omposition and inﬂammatory proﬁle in females. These results are
onsistent with previous ﬁndings that indicate higher fat mass and
eptin levels in women than men  [12,19,38,56]. However, the abso-
ute value of change was similar between boys and girls in both
eptin concentrations and also in depression symptoms, which indi-
ates that they improved similarly on these parameters. Even so,
t was observed that the tested ‘leptin-depression’ hypothesis was
onﬁrmed only in girls, but not in boys, suggesting that gender may
lay an important role in leptin-predicted depressive symptoms.
Indeed, there is some previous evidence regarding gender dif-
erences in the relationship between leptin and depression [50],
lthough the data are not consistent. In agreement with the present
tudy, Esel et al. [12] showed a positive correlation between leptin
oncentrations and severity of depression in women both before
nd also in longitudinal analyses after antidepressant treatment,
hich was not conﬁrmed in men. Also, Antonijevic et al. [2] found
 greater plasma leptin concentration in depressed females (but not
ales) when compared to controls. Häfner et al. [21] demonstrated
 relationship between depressed mood and sleep disturbances and
eptin levels in women but not in men. However, divergent data
howed an increased risk for elevated leptin levels in healthy men
ith depressed mood and social isolation but not in women, as
ell as an association between depressed mood and social isola-
ion with IL-6, another inﬂammatory marker, only in men  [20].
n the other hand, Kraus et al. [29], Jown et al. [27] and Yang
t al. [56] have demonstrated lower levels of leptin in depressive
isorder subjects compared to healthy controls. Moreover, Cizza
t al. [8] and Deuschle et al. [11] have not found any associations
etween leptin and depression in men  or women and Olszanecka-
linianowicz et al. [44] have not found associations between leptin
nd depressive category in obese women.
It should be mentioned that the cited studies are mainly cross-
ectional and evaluate only adults. Moreover, the majority of
tudies evaluate depressive population, in contrast with the present
nvestigation which evaluated depressive symptoms in an obese
opulation. Hood et al. [22] showed that greater metabolic abnor-
alities, such as leptin, are associated with higher depressive
ategories in adolescents with diabetes, however, this was  also a
ross-sectional study and they did not test for gender differences.eptides 65 (2015) 20–28
Therefore, the present investigation presents a novel ﬁnding that
may  be helpful for the understanding of the role of leptin on the
amelioration of depressive symptoms during weight loss in obese
adolescents, especially in girls.
Some hypothesis can be raised to explain the gender differences,
although data are not conclusive. Esel et al. [12] point out the HPA
system hypothesis, on which the increase in leptin may  be due to
the HPA system hyperactivity and enhanced glucocorticoids, which
stimulate gene expression and production of leptina independently
of their effect on food intake. Therefore, they suggested that female
adipose tissue might have a greater sensitivity to glucocorticoids,
which may  underlie the sexually dimorphic patter observed in the
association between leptin and depression. This assumption helps
explain such differences between girls and boys on the present
investigation.
Lastly, it is known that the etiology of depression in women
seems to be more complex than in men, with an important role of
psychosocial events, such as social support and stressful life events
[28,33]. Thus, as was  previously stated, mechanisms of stress reg-
ulations are suggested to play an important role in the association
between leptin and depression. This sense, this gender differences
in the etiology of depression may  contribute to elucidate the dif-
ferences found on the present investigation. Nevertheless, further
research is needed to clarify these results.
In addition to its association with leptin and leptin/adiponectin
ratio, the improvement in depressive symptoms was  correlated
with other important parameters of health and quality of life for
obese individuals. Speciﬁcally, changes in depression correlated
with changes in body mass, BMI, fat mass and subcutaneous fat,
but also remained only for girls with exception for subcutaneous
fat that also remained correlated in boys when analyzed separately.
These results suggest an association between mental and physi-
cal health that need to be considered in the treatment of obese
adolescents.
Moreover, as expected, changes in leptin concentrations showed
positive correlations with changes in body mass and BMI, fat mass
(% and kg), visceral fat, subcutaneous fat and leptin/adiponectin
ratio. Inversely, leptin was negatively correlated with lean mass (%)
and adiponectin/leptin ratio. This results are in agreement with pre-
vious ones that showed associations between weight loss and the
improvement of body composition and the reduction of leptinemia
[23,31,40] and also corroborate the hypothesis that hyperleptine-
mia  plays an important role in pro-inﬂammatory status related
to obesity, as previously demonstrated by Sanches et al. [51]. All
together, these ameliorations are critical to the management of
obesity-related diseases and demonstrate its relationships with the
attenuation of hyperleptinemia, conﬁrming the importance of lep-
tin as a target for obesity treatment.
Lastly, it is important to emphasize that the results presented
in this investigation are not intended to suggest that leptinemia is
the exclusive cause of depression in the context of obesity. Depres-
sion is a multi-factorial and highly complex condition and it is not
useful to reduce its etiology to a single cause. It is worth noting
that, according to Carr et al. [6], obese individuals report greater
mistreatment in interpersonal relationships, such as disrespectful
treatment, harassment or provocation, and obese status is often
perceived as a ﬂaw of character. In this way, obese individuals fre-
quently endure stigmatizing experiences that promote body image
dissatisfaction and depression.
Indeed, Markowitz et al. [36] propose that behavioral, cognitive
and social mechanisms – functional impairment, repeated dieting,
body image dissatisfaction, stigma, are likely to all play a role in
the obesity–depression pathway. Moreover, they point out that
the literature suggests some independent risk factors for comorbid
obesity and depression, such as severity of obesity, female gender
and high socioeconomic status.
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onclusion
In conclusion, the present investigation demonstrated that the
eduction in leptin concentrations, and attenuation of leptine-
ia, is a predictor of the reduction in depressive symptoms in
bese adolescents during weight loss, which appears to be inde-
endent from changes in anthropometric and body composition
roﬁle, especially in girls. Although there is evidence in the lit-
rature about the relationship between leptin and depression,
o previous research has established this relationship in adoles-
ents during weight loss therapy. Establishing a role for leptin in
epression during long-term weight loss therapy may  be valu-
ble for identifying further targets for treatment. The present
tudy involved a non-pharmacological treatment strategy based
n lifestyle changes that can promote weight loss. However, the
otential differences between pharmacological anti-depressive
reatment and behavioral approaches to weight loss should be con-
idered in future clinical treatments. Nevertheless, these results
elp to strengthen the hypothesis that leptinemia has an active role
n depressive disorder. The present outcomes further clarify that a
pro-inﬂammatory) hyperleptinemic state is an important factor in
nderstanding the association between weight loss and depression
n obese adolescents.
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